5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment
DiscussionThe findings of the 5-EPIFAT trial could be helpful to guide clinical decision-making, personalization treatment approach, design of future trials, as well as the development of CRF management guidelines.Trial registrationIRCT.ir IRCT20150302021307N6. Registered on 13 May 2023.
Source: Trials - Category: Research Source Type: clinical trials
More News: Amantadine | Bupropion | Cancer | Cancer & Oncology | Clinical Trials | Concerta | Eyes | Ginseng | Learning | Methylphenidate | Research | Ritalin | Study | Symmetrel | Universities & Medical Training | Wellbutrin